BioSpace News Archive

WebMD announced that accomplished journalist and senior digital content executive Leah Gentry has joined the organization as Group Vice President, Content.

Bio-engineered analog of CBD (CBDVHS) exhibited highly significant potency when compared to CBD in lowering biomarkers associated with inflammation and fibrosis in a validated human tissue model of ocular disease Contrary to historical studies of CBD, CBDVHS was not associated with an elevation in intraocular pressure Long Beach, Calif., June 09, 2020 (GLOBE NEWSWIRE) -- -- Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address g

Preliminary Findings of T1D Exchange’s Population Health Surveillance Study of COVID-19 in Individuals with Type 1 Diabetes Published in Diabetes Care First U.S. based, multi-center study to examine patient characteristics and adverse outcomes to drive advances in quality improvement and care best practices BOSTON--( BUSINESS WIRE )-- T1D Exchange announced that preliminary results of its population health surveillance study, “ Type 1 Diabetes and

AMPEL BioSolutions announces genomic analysis and findings that could improve treatment of COVID19 patients with approved drugs such as Embrel and Stelara. Published on bioRxiv as a preprint, the study reveals a gene-based test that will be able to determine those patients who may progress to severe illness with increased like

Premier Medical Laboratory Services, a top commercial diagnostic laboratory is now expanding their COVID-19 testing portfolio by adding antibody testing to their offerings.

Funds to be Used for Manufacturing Capacity Expansion of Commercially Available Testing Kit and to Support Pathway to Production of Vaccine Candidate(s) for Clinical Trials

On June 4 th , Immunovia announced a Directed Share Issue raising ~400 MSEK in capital, resulting in one of the largest fundraising for a non-US based diagnostics company. Proceeds from this Directed Share Issue will be used for the commercialization activities associated with the launch of IMMray ™ PanCan-d. These activities include

Seven Indiana cities are recognized for their national life science strengths, according to Biotechnology Industry Organization (BIO) and TEConomy Partners’ biennial survey of the U.S. life sciences industry released today. Bloomingto

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association 80th scientific sessions virtual meeting, June 12-16, 2020. Medtronic will be participating in this year’s ADA virtual sessions with 16 data presentations, a symposium, a product theater, and a virtual exhibit.

Through the JDRF – Beyond Type 1 Alliance, Beyond Type 1 has partnered with JDRF — the world’s leading nonprofit funder of Type 1 diabetes (T1D) research — to educate the T1D community and the general public about current scientific developments, including the path to a cure for the chronic autoimmune condition.